Save time and get answers to complex questions with AI chat
Defitelio defibrotide sodium drug profile 2024 drugpatentwatch?How does lipitor's effectiveness differ for arthritis pain?Is guselkumab off patent in u s?Prolia and osteonecrosis?Brenzavvy discontinuation?
See the DrugPatentWatch profile for tremfya
Short answer: No. Tremfya (guselkumab) does not have a generic version available in the U.S. Right now, there are no FDA-approved generic versions or guselkumab biosimilars. Notes: - Because Tremfya is a biologic (a monoclonal antibody), it doesn’t have traditional “generics.” Instead, a biosimilar would be the closest equivalent. As of today, there are no FDA-approved guselkumab biosimilars in the U.S. - Status can change, and approvals can vary by region (EU, other countries). If you’re outside the U.S. or want the latest status, I can help look up current approvals or provide sources to check (FDA Drug Sources, EMA, etc.). - If cost is a concern, talk with your doctor or pharmacist about alternatives (other biologics or small-molecule options) and about any approved biosimilars if they become available in your area. Would you like me to check the latest status for a specific country or region?
Other Questions About Tremfya :